159 related articles for article (PubMed ID: 36707804)
1. Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development.
Chai H; Pan C; Zhang M; Huo H; Shan H; Wu J
BMC Cancer; 2023 Jan; 23(1):96. PubMed ID: 36707804
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer.
Ishii T; Akiyama Y; Shimada S; Kabashima A; Asano D; Watanabe S; Ishikawa Y; Ueda H; Akahoshi K; Ogawa K; Ono H; Kudo A; Tanabe M; Tanaka S
Cancer Sci; 2023 Feb; 114(2):463-476. PubMed ID: 36271761
[TBL] [Abstract][Full Text] [Related]
3. Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer.
Wu J; Chai H; Xu X; Yu J; Gu Y
Mol Oncol; 2020 Jun; 14(6):1397-1409. PubMed ID: 32291851
[TBL] [Abstract][Full Text] [Related]
4. Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer.
Li M; Shi M; Xu Y; Qiu J; Lv Q
Cell Transplant; 2021; 30():9636897211027521. PubMed ID: 34705580
[TBL] [Abstract][Full Text] [Related]
5. Histone Methyltransferase SETD1A Induces Epithelial-Mesenchymal Transition to Promote Invasion and Metastasis Through Epigenetic Reprogramming of Snail in Gastric Cancer.
Wu J; Chai H; Shan H; Pan C; Xu X; Dong W; Yu J; Gu Y
Front Cell Dev Biol; 2021; 9():657888. PubMed ID: 34164392
[TBL] [Abstract][Full Text] [Related]
6. Histone methyltransferase SETD1A participates in lung cancer progression.
Du M; Gong P; Zhang Y; Liu Y; Liu X; Zhang F; Wang X
Thorac Cancer; 2021 Aug; 12(16):2247-2257. PubMed ID: 34219384
[TBL] [Abstract][Full Text] [Related]
7. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.
Zhu W; Niu J; He M; Zhang L; Lv X; Liu F; Jiang L; Zhang J; Yu Z; Zhao L; Bi J; Yan Y; Wei Q; Huo H; Fan Y; Chen Y; Ding J; Wei M
J Transl Med; 2019 Aug; 17(1):259. PubMed ID: 31395064
[TBL] [Abstract][Full Text] [Related]
8. SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinoma.
Wu J; Chai H; Li F; Ren Q; Gu Y
Life Sci; 2020 Nov; 260():118406. PubMed ID: 32918976
[TBL] [Abstract][Full Text] [Related]
9. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of SETD1A promotes survival and migration of estrogen receptor α-positive breast cancer cells.
Jin ML; Kim YW; Jin HL; Kang H; Lee EK; Stallcup MR; Jeong KW
Int J Cancer; 2018 Dec; 143(11):2871-2883. PubMed ID: 30191958
[TBL] [Abstract][Full Text] [Related]
11. GASC1 promotes glioma progression by enhancing NOTCH1 signaling.
Xiao Z; Yang X; Liu Z; Shao Z; Song C; Zhang K; Wang X; Li Z
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649841
[TBL] [Abstract][Full Text] [Related]
12. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract][Full Text] [Related]
13. An SETD1A/Wnt/β-catenin feedback loop promotes NSCLC development.
Wang R; Liu J; Li K; Yang G; Chen S; Wu J; Xie X; Ren H; Pang Y
J Exp Clin Cancer Res; 2021 Oct; 40(1):318. PubMed ID: 34645486
[TBL] [Abstract][Full Text] [Related]
14. The H3K4 methyltransferase SETD1A is required for proliferation of non-small cell lung cancer cells by promoting S-phase progression.
Kang JY; Park JW; Hwang Y; Hahm JY; Park J; Park KS; Seo SB
Biochem Biophys Res Commun; 2021 Jul; 561():120-127. PubMed ID: 34023776
[TBL] [Abstract][Full Text] [Related]
15. NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression.
Jeong GY; Park MK; Choi HJ; An HW; Park YU; Choi HJ; Park J; Kim HY; Son T; Lee H; Min KW; Oh YH; Lee JY; Kong G
Cancer Res; 2021 Jan; 81(1):77-90. PubMed ID: 32967925
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA GClnc1 knockdown suppresses progression of epithelial ovarian cancer by recruiting FOXC2 to disrupt the NOTCH1/NF-κB/Snail pathway.
Wu D; Ke Y; Xiao R; Liu J; Li Q; Wang Y
Exp Cell Res; 2021 Feb; 399(1):112422. PubMed ID: 33338479
[TBL] [Abstract][Full Text] [Related]
17. HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.
Li N; Gou JH; Xiong J; You JJ; Li ZY
BMC Cancer; 2020 Mar; 20(1):222. PubMed ID: 32178630
[TBL] [Abstract][Full Text] [Related]
18. Elevated placental histone H3K4 methylation via upregulated histone methyltransferases SETD1A and SMYD3 in preeclampsia and its possible involvement in hypoxia-induced pathophysiological process.
Matsui H; Iriyama T; Sayama S; Inaoka N; Suzuki K; Yoshikawa M; Ichinose M; Sone K; Kumasawa K; Nagamatsu T; Fujisawa T; Naguro I; Ichijo H; Fujii T; Osuga Y
Placenta; 2021 Nov; 115():60-69. PubMed ID: 34560329
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway.
Zou W; Ma X; Hua W; Chen B; Cai G
Oncol Rep; 2015 Dec; 34(6):3256-63. PubMed ID: 26503358
[TBL] [Abstract][Full Text] [Related]
20. SETD1A-mediated H3K4me3 methylation upregulates lncRNA HOXC-AS3 and the binding of HOXC-AS3 to EP300 and increases EP300 stability to suppress the ferroptosis of NSCLC cells.
Shi Z; Zhang H; Shen Y; Zhang S; Zhang X; Xu Y; Sun D
Thorac Cancer; 2023 Sep; 14(25):2579-2590. PubMed ID: 37548102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]